Description
Our client is a pre-IPO company with a recent $100+ million funding round focused on developing oncology therapeutics using a new treatment modality.
Responsibilities include but are not limited to:
* Drive preclinical oncology programs forward.
* Develop and execute strategy for target validation, cell activity screening, demonstration of in vitro and in vivo proof of concept, and identification of pharmacodynamic and patient selection biomarkers.
* Participate in evaluation and selection of new targets.
* Manage CROs for some molecular biology needs and for in vivo studies.
* Build and maintain a motivated team of scientists and research associates.
Qualified candidates will have:
* PhD degree in Cell or Molecular Biology, Genetics, Biochemistry, or related discipline and 10+ years of post-degree experience, with 3+ years of people management experience. Ideally, you have demonstrated success in leading multiple oncology drug development programs from inception through IND.
This is an excellent opportunity to take a leadership role in bringing a new and potentially transformational drug modality to patients in need. Contact for more information.
Must be authorized to work in the US indefinitely to be considered. All resumes will be kept strictly confidential until you choose to pursue a specific opportunity with one of our clients.
*
